Skip to main content
Download PDF

Correction to: Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy

Journal of Hematology & Oncology volume 14, Article number: 150 (2021) Cite this article

The Original Article was published on 05 July 2021

Correction to: J Hematol Oncol (2021) 14:106 https://doi.org/10.1186/s13045-021-01120-3

The original article [1] contained a minor error in the Additional file which has since been corrected.

Reference

  1. Wang C, et al. Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy. J Hematol Oncol. 2021;14:106. https://doi.org/10.1186/s13045-021-01120-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. Jing Nie and Weidong Han jointly supervise this work

  2. Chunmeng Wang and Fengxia Shi are co-first author

Authors and Affiliations

  1. Department of Bio-Therapeutic, The First Medical Centre in Chinese PLA General Hospital, Beijing, China

    Chunmeng Wang, Fengxia Shi, Yang Liu, Yajing Zhang, Liang Dong, Xiang Li, Chuan Tong, Yao Wang, Jing Nie & Weidong Han

  2. Department of Hematology, Shanxi Cancer Hospital, Taiyuan, Shanxi, China

    Liping Su

Authors
  1. Chunmeng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fengxia Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yajing Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Liang Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chuan Tong
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yao Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Liping Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jing Nie
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Weidong Han
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jing Nie or Weidong Han.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, C., Shi, F., Liu, Y. et al. Correction to: Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy. J Hematol Oncol 14, 150 (2021). https://doi.org/10.1186/s13045-021-01154-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13045-021-01154-7

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us